nodes	percent_of_prediction	percent_of_DWPC	metapath
Betazole—HRH2—coronary artery disease	0.94	1	CbGaD
Betazole—HRH2—Signaling by GPCR—FZD2—coronary artery disease	0.00013	0.00214	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—UTS2R—coronary artery disease	0.00013	0.00214	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—OPRD1—coronary artery disease	0.000127	0.00209	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADORA3—coronary artery disease	0.000125	0.00206	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADORA1—coronary artery disease	0.000125	0.00206	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR7—coronary artery disease	0.000125	0.00206	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PPBP—coronary artery disease	0.000121	0.00199	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—KNG1—coronary artery disease	0.000118	0.00196	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—AGTR1—coronary artery disease	0.000118	0.00195	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—AVPR1A—coronary artery disease	0.000117	0.00193	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADM2—coronary artery disease	0.000117	0.00193	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CXCL10—coronary artery disease	0.000115	0.0019	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCL4—coronary artery disease	0.000115	0.0019	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—OPRD1—coronary artery disease	0.000115	0.0019	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.000115	0.0019	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.000114	0.00189	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—UTS2—coronary artery disease	0.000113	0.00187	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—ADRB2—coronary artery disease	0.000112	0.00185	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TMED2—coronary artery disease	0.000111	0.00183	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PLCB3—coronary artery disease	0.000109	0.00181	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—P2RY12—coronary artery disease	0.000109	0.00181	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.000109	0.0018	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CASR—coronary artery disease	0.000108	0.00179	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—AVPR1A—coronary artery disease	0.000106	0.00175	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—GNA12—coronary artery disease	0.000106	0.00175	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—BDKRB1—coronary artery disease	0.000106	0.00175	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—LRP8—coronary artery disease	0.000105	0.00174	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RLN3—coronary artery disease	0.000105	0.00174	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DGKZ—coronary artery disease	0.000105	0.00174	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADM—coronary artery disease	0.000103	0.00171	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—UTS2—coronary artery disease	0.000102	0.00169	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EDN2—coronary artery disease	0.000101	0.00167	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AES—coronary artery disease	0.000101	0.00167	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PDE4B—coronary artery disease	0.000101	0.00166	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.000101	0.00166	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—EDN1—coronary artery disease	9.98e-05	0.00165	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PLCB3—coronary artery disease	9.93e-05	0.00164	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—P2RY12—coronary artery disease	9.93e-05	0.00164	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CCL5—coronary artery disease	9.9e-05	0.00164	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CX3CR1—coronary artery disease	9.83e-05	0.00162	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CASR—coronary artery disease	9.83e-05	0.00162	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—BDKRB1—coronary artery disease	9.64e-05	0.00159	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—GNA12—coronary artery disease	9.64e-05	0.00159	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CX3CL1—coronary artery disease	9.64e-05	0.00159	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PPP3R1—coronary artery disease	9.46e-05	0.00156	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADM—coronary artery disease	9.37e-05	0.00155	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CCR3—coronary artery disease	9.2e-05	0.00152	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	9.16e-05	0.00151	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PDE4B—coronary artery disease	9.14e-05	0.00151	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	8.96e-05	0.00148	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ACVR1B—coronary artery disease	8.83e-05	0.00146	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RHOC—coronary artery disease	8.83e-05	0.00146	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR2A—coronary artery disease	8.73e-05	0.00144	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—C3—coronary artery disease	8.72e-05	0.00144	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CXCL2—coronary artery disease	8.65e-05	0.00143	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NEDD4—coronary artery disease	8.59e-05	0.00142	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—F2R—coronary artery disease	8.55e-05	0.00141	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PDE3A—coronary artery disease	8.37e-05	0.00138	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RAMP2—coronary artery disease	8.37e-05	0.00138	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MDK—coronary artery disease	8.37e-05	0.00138	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PF4—coronary artery disease	8.37e-05	0.00138	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCR3—coronary artery disease	8.36e-05	0.00138	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—EDNRB—coronary artery disease	8.28e-05	0.00137	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—AGT—coronary artery disease	8.28e-05	0.00137	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—F2RL1—coronary artery disease	7.99e-05	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RALBP1—coronary artery disease	7.99e-05	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NPY5R—coronary artery disease	7.99e-05	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CXCL2—coronary artery disease	7.86e-05	0.0013	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCL3—coronary artery disease	7.86e-05	0.0013	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—EDNRA—coronary artery disease	7.82e-05	0.00129	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADRB1—coronary artery disease	7.79e-05	0.00129	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—F2R—coronary artery disease	7.77e-05	0.00128	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—FZD2—coronary artery disease	7.66e-05	0.00127	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—UTS2R—coronary artery disease	7.66e-05	0.00127	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—F2—coronary artery disease	7.65e-05	0.00127	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—EDNRB—coronary artery disease	7.52e-05	0.00124	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SFRP2—coronary artery disease	7.51e-05	0.00124	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADORA1—coronary artery disease	7.37e-05	0.00122	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOA4—coronary artery disease	7.37e-05	0.00122	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADORA3—coronary artery disease	7.37e-05	0.00122	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CXCL12—coronary artery disease	7.36e-05	0.00122	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—BDKRB2—coronary artery disease	7.36e-05	0.00122	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PLCB1—coronary artery disease	7.19e-05	0.00119	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PGF—coronary artery disease	7.12e-05	0.00118	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PPBP—coronary artery disease	7.12e-05	0.00118	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—EDNRA—coronary artery disease	7.1e-05	0.00117	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	7.08e-05	0.00117	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADRB1—coronary artery disease	7.07e-05	0.00117	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR7—coronary artery disease	7.04e-05	0.00116	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ITGA2B—coronary artery disease	7.01e-05	0.00116	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DVL1—coronary artery disease	7.01e-05	0.00116	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—POMC—coronary artery disease	6.97e-05	0.00115	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CCL2—coronary artery disease	6.82e-05	0.00113	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCL4—coronary artery disease	6.79e-05	0.00112	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GHR—coronary artery disease	6.79e-05	0.00112	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—OPRD1—coronary artery disease	6.79e-05	0.00112	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—KNG1—coronary artery disease	6.69e-05	0.00111	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CXCL12—coronary artery disease	6.68e-05	0.0011	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—BDKRB2—coronary artery disease	6.68e-05	0.0011	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—AGTR1—coronary artery disease	6.65e-05	0.0011	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PLCB1—coronary artery disease	6.53e-05	0.00108	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MEF2A—coronary artery disease	6.51e-05	0.00108	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TLE4—coronary artery disease	6.51e-05	0.00108	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CXCL10—coronary artery disease	6.5e-05	0.00107	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR7—coronary artery disease	6.4e-05	0.00106	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOA2—coronary artery disease	6.35e-05	0.00105	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADRB2—coronary artery disease	6.31e-05	0.00104	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AVPR1A—coronary artery disease	6.27e-05	0.00104	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PRKCE—coronary artery disease	6.23e-05	0.00103	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—KNG1—coronary artery disease	6.08e-05	0.001	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—UTS2—coronary artery disease	6.05e-05	0.001	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—AGTR1—coronary artery disease	6.04e-05	0.000999	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NR4A1—coronary artery disease	5.93e-05	0.000979	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CXCL10—coronary artery disease	5.9e-05	0.000976	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PLCB3—coronary artery disease	5.86e-05	0.000969	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HDAC9—coronary artery disease	5.86e-05	0.000969	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—P2RY12—coronary artery disease	5.86e-05	0.000969	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CX3CR1—coronary artery disease	5.81e-05	0.00096	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CASR—coronary artery disease	5.81e-05	0.00096	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADRB2—coronary artery disease	5.73e-05	0.000947	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GNA12—coronary artery disease	5.69e-05	0.000941	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—BDKRB1—coronary artery disease	5.69e-05	0.000941	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—P4HB—coronary artery disease	5.69e-05	0.000941	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CX3CL1—coronary artery disease	5.69e-05	0.000941	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PRKCE—coronary artery disease	5.66e-05	0.000935	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—EDN1—coronary artery disease	5.64e-05	0.000932	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CCL5—coronary artery disease	5.6e-05	0.000925	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PPP3R1—coronary artery disease	5.59e-05	0.000924	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADM—coronary artery disease	5.54e-05	0.000915	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CSF2—coronary artery disease	5.51e-05	0.000911	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PDE4B—coronary artery disease	5.4e-05	0.000892	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CYBB—coronary artery disease	5.4e-05	0.000892	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—CXCL8—coronary artery disease	5.39e-05	0.000892	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—MMP3—coronary artery disease	5.38e-05	0.00089	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—EDN1—coronary artery disease	5.12e-05	0.000847	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCL5—coronary artery disease	5.08e-05	0.00084	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PRKCD—coronary artery disease	5.04e-05	0.000833	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CSF2—coronary artery disease	5.01e-05	0.000827	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCR3—coronary artery disease	4.94e-05	0.000816	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR2A—coronary artery disease	4.93e-05	0.000816	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—C3—coronary artery disease	4.93e-05	0.000814	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CRK—coronary artery disease	4.87e-05	0.000805	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SH2B3—coronary artery disease	4.81e-05	0.000795	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ATP2A2—coronary artery disease	4.81e-05	0.000795	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—VWF—coronary artery disease	4.81e-05	0.000795	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOC3—coronary artery disease	4.78e-05	0.00079	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—LDLR—coronary artery disease	4.75e-05	0.000785	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—AGT—coronary artery disease	4.68e-05	0.000774	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PPP2CA—coronary artery disease	4.66e-05	0.000771	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CXCL2—coronary artery disease	4.64e-05	0.000767	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCL3—coronary artery disease	4.64e-05	0.000767	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SDC1—coronary artery disease	4.59e-05	0.000759	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—F2R—coronary artery disease	4.59e-05	0.000759	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PRKCD—coronary artery disease	4.58e-05	0.000757	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—FGB—coronary artery disease	4.49e-05	0.000742	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR2A—coronary artery disease	4.48e-05	0.000741	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—C3—coronary artery disease	4.47e-05	0.00074	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EDNRB—coronary artery disease	4.44e-05	0.000735	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—THBS1—coronary artery disease	4.38e-05	0.000724	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PSMA6—coronary artery disease	4.34e-05	0.000717	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PSMB5—coronary artery disease	4.34e-05	0.000717	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—F2—coronary artery disease	4.33e-05	0.000715	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—AGT—coronary artery disease	4.25e-05	0.000703	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EDNRA—coronary artery disease	4.2e-05	0.000694	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CYBA—coronary artery disease	4.18e-05	0.000691	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADRB1—coronary artery disease	4.18e-05	0.000691	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DUSP6—coronary artery disease	4.16e-05	0.000688	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PLAT—coronary artery disease	4.09e-05	0.000676	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CXCL12—coronary artery disease	3.95e-05	0.000652	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—BDKRB2—coronary artery disease	3.95e-05	0.000652	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—POMC—coronary artery disease	3.94e-05	0.000651	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—F2—coronary artery disease	3.93e-05	0.000649	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—IL6ST—coronary artery disease	3.91e-05	0.000647	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—JUNB—coronary artery disease	3.87e-05	0.00064	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PLCB1—coronary artery disease	3.86e-05	0.000638	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR7—coronary artery disease	3.78e-05	0.000625	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ITGAV—coronary artery disease	3.6e-05	0.000595	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—KNG1—coronary artery disease	3.59e-05	0.000593	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—POMC—coronary artery disease	3.58e-05	0.000591	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CREB1—coronary artery disease	3.58e-05	0.000591	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AGTR1—coronary artery disease	3.57e-05	0.00059	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CCL2—coronary artery disease	3.5e-05	0.000579	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—IL6R—coronary artery disease	3.49e-05	0.000577	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CXCL10—coronary artery disease	3.49e-05	0.000576	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PLG—coronary artery disease	3.48e-05	0.000575	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADRB2—coronary artery disease	3.39e-05	0.00056	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PRKCE—coronary artery disease	3.34e-05	0.000553	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—JAK2—coronary artery disease	3.34e-05	0.000552	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SOCS1—coronary artery disease	3.33e-05	0.000551	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—S100B—coronary artery disease	3.33e-05	0.00055	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SOCS3—coronary artery disease	3.29e-05	0.000544	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TGFBR2—coronary artery disease	3.25e-05	0.000538	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—KITLG—coronary artery disease	3.25e-05	0.000538	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MMP3—coronary artery disease	3.18e-05	0.000526	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—STAT5A—coronary artery disease	3.18e-05	0.000526	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOB—coronary artery disease	3.07e-05	0.000508	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—CXCL8—coronary artery disease	3.05e-05	0.000504	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—JAK2—coronary artery disease	3.03e-05	0.000501	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—EDN1—coronary artery disease	3.03e-05	0.0005	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCL5—coronary artery disease	3e-05	0.000496	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—FGF1—coronary artery disease	2.96e-05	0.000489	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CSF2—coronary artery disease	2.96e-05	0.000489	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—LPL—coronary artery disease	2.94e-05	0.000485	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RPS6KB1—coronary artery disease	2.91e-05	0.000481	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MEF2C—coronary artery disease	2.91e-05	0.000481	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ITGB3—coronary artery disease	2.83e-05	0.000469	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—CXCL8—coronary artery disease	2.77e-05	0.000458	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PPP2CA—coronary artery disease	2.75e-05	0.000455	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PRKCD—coronary artery disease	2.7e-05	0.000447	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR2A—coronary artery disease	2.65e-05	0.000437	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—C3—coronary artery disease	2.64e-05	0.000437	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HIF1A—coronary artery disease	2.52e-05	0.000417	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AGT—coronary artery disease	2.51e-05	0.000415	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—LEP—coronary artery disease	2.46e-05	0.000407	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOE—coronary artery disease	2.46e-05	0.000407	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—APOA1—coronary artery disease	2.43e-05	0.000402	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—KDR—coronary artery disease	2.41e-05	0.000398	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MAPK14—coronary artery disease	2.39e-05	0.000396	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ESR1—coronary artery disease	2.35e-05	0.000388	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—F2—coronary artery disease	2.32e-05	0.000384	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—FN1—coronary artery disease	2.32e-05	0.000384	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—IL6ST—coronary artery disease	2.31e-05	0.000382	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NFKBIA—coronary artery disease	2.29e-05	0.000379	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—KIT—coronary artery disease	2.22e-05	0.000367	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GSK3B—coronary artery disease	2.13e-05	0.000352	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CREB1—coronary artery disease	2.11e-05	0.000349	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—POMC—coronary artery disease	2.11e-05	0.000349	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCL2—coronary artery disease	2.07e-05	0.000342	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—IL6R—coronary artery disease	2.06e-05	0.000341	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—IGF1—coronary artery disease	2.03e-05	0.000336	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—MAPK1—coronary artery disease	2.02e-05	0.000334	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.93e-05	0.00032	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—SERPINE1—coronary artery disease	1.93e-05	0.000319	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—FGF2—coronary artery disease	1.87e-05	0.000309	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NOS3—coronary artery disease	1.84e-05	0.000305	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—JAK2—coronary artery disease	1.79e-05	0.000296	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PIK3CA—coronary artery disease	1.76e-05	0.00029	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CXCL8—coronary artery disease	1.64e-05	0.00027	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—AKT1—coronary artery disease	1.58e-05	0.000261	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CASP3—coronary artery disease	1.56e-05	0.000259	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—IL6—coronary artery disease	1.55e-05	0.000257	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—CCND1—coronary artery disease	1.52e-05	0.000252	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MMP9—coronary artery disease	1.48e-05	0.000244	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—AKT1—coronary artery disease	1.43e-05	0.000237	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—VEGFA—coronary artery disease	1.33e-05	0.00022	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TGFB1—coronary artery disease	1.22e-05	0.000201	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—MAPK1—coronary artery disease	1.2e-05	0.000198	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-05	0.000171	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—IL6—coronary artery disease	9.18e-06	0.000152	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AKT1—coronary artery disease	8.47e-06	0.00014	CbGpPWpGaD
